Home/Editorial Board

Editorial Board

Journal of ImmunoTherapy of Cancer Editorial Board members have agreed and adhere to the BMJ Editor Roles and Responsibilities guidelines; including our Editor policy on competing interests.

Editor-in-Chief

Pedro J. Romero, MD University of Lausanne, Switzerland Declaration of Interests

Deputy Editor-in-Chief

James L. Gulley, MD, PhD, FACP National Cancer Institute, National Institutes of Health, United States Declaration of Interests

Basic Tumor Immunology

Section Editor
Cornelis J. M. Melief, MD, PhD
Leiden University Medical Center, the Netherlands
Sjoerd H. van der Burg, PhD
Leiden University Medical Center, the Netherlands
ORCID logo orcid.org/0000-0002-6556-0354
Associate Editors
Scott I. Abrams, PhD
Roswell Park Cancer Institute, United States

Timothy NJ Bullock, PhD
University of Virginia, United States
ORCID logo orcid.org/0000-0001-6141-3261

Gennaro Ciliberto, MD
IRCCS Istituto Nazionale Tumori Regina Elena, Italy
ORCID logo orcid.org/0000-0003-2851-8605

Khashayarsha Khazaie, PhD, DSc
Mayo Clinic College of Medicine, United States

Eric Tartour, MD, PhD
Hôpital Européen Georges Pompidou, France

Viktor Umansky, PhD
German Cancer Research Center (DKFZ), Germany

Case Reports

Section Editor
Alfred Zippelius, MD
University Hospital Basel, Switzerland
ORCID logo orcid.org/0000-0003-1933-8178
Deputy Editor
Matthew D. Hellmann, MD AstraZeneca, United States ORCID logo orcid.org/0000-0002-2670-9777
Associate Editors
Jack D. Bui, MD, PhD University of California San Diego, United States ORCID logo orcid.org/0000-0002-9324-368X Sebastian Kobold, MD Klinikum der Universität München, Germany
Heinz Läubli, MD, PhD University Hospital Basel, Switzerland ORCID logo orcid.org/0000-0002-8910-5620

Clinical/Translational Cancer Immunotherapy

Section Editors
Douglas G. McNeel, MD, PhD University of Wisconsin Carbone Cancer Center, United States ORCID logo orcid.org/0000-0003-1471-6723 Claudia Palena, PhD National Cancer Institute, National Institutes of Health, United States
Jeffrey S. Weber, MD, PhD New York University Langone Medical Center, United States ORCID logo orcid.org/0000-0002-4962-2957
Associate Editors
Paolo Antonio Ascierto, MD Istituto Nazional Tumori-Fondazione ‘G.Pascale’, Italy ORCID logo orcid.org/0000-0002-8322-475X Richard D. Carvajal, MD Columbia University Irving Medical Center, United States Tanja D. de Gruijl, PhD Amsterdam University Medical Centers, the Netherlands ORCID logo orcid.org/0000-0003-1464-8978 Brian R. Gastman, MD Cleveland Clinic Cancer Center, United States Margaret E. Gatti-Mays, MD, MPH Ohio State University Comprehensive Cancer Center, United States ORCID logo orcid.org/0000-0001-8914-2897 Christian S. Hinrichs, MD Rutgers Cancer Institute of New Jersey, United States ORCID logo orcid.org/0000-0001-5597-2841 Hongbo Hu, PhD West China Hospital, Sichuan University, China Douglas B. Johnson, MD, MSCI Vanderbilt University Medical Center, United States
Pawel Kalinski, MD, PhD Roswell Park Cancer Institute, United States Dung Le, MD Johns Hopkins University, United States Yangqiu Li, MD Jinan University School of Medicine, China Jason J. Luke, MD, FACP University of Pittsburgh Medical Center, United States ORCID logo orcid.org/0000-0002-1182-4908 Ravi A. Madan, MD National Cancer Institute, National Institutes of Health, United States ORCID logo orcid.org/0000-0001-5106-8636 Luca Mazzarella, MD, PhD European Institute of Oncology, Italy ORCID logo orcid.org/0000-0002-4043-3279 Anna Obenauf, PhD Research Institute of Molecular Pathology, Austria Ravi Patel, MD, PhD University of Pittsburgh, United States ORCID logo orcid.org/0000-0002-8328-746X

Clinical Trials Monitor

Section Editor
Leisha A. Emens, MD, PhD UPMC Hillman Cancer Center, United States ORCID logo orcid.org/0000-0002-7694-0731
Associate Editors
Tai-Tsang Chen, PhD Columbia University; Bristol-Myers Squibb, United States Jolanda de Vries, PhD Radboud University Nijmegen, the Netherlands
Larry W. Kwak, MD, PhD City of Hope, United States ORCID logo orcid.org/0000-0002-1884-5349 Kunle Odunsi, MD, PhD University of Chicago Medicine Comprehensive Cancer Center, United States Louis M. Weiner, MD Georgetown-Lombardi Comprehensive Cancer Center, United States ORCID logo orcid.org/0000-0001-5192-0710

Commentary/Editorials

Section Editor
Christian M. Capitini, MD University of Wisconsin, Madison, United States ORCID logo orcid.org/0000-0002-2276-6731
Associate Editors
Ana Carrizosa Anderson, MD Harvard University, United States ORCID logo orcid.org/0000-0002-0877-2932 Bryon D. Johnson, PhD Medical College of Wisconsin, United States William J. Murphy, PhD University of California, Davis, United States ORCID logo orcid.org/0000-0002-2793-401X
Gabriel Rabinovich, PhD Instituto de Biologia y Medicina Experimental (IByME), Argentina ORCID logo orcid.org/0000-0002-0947-8735 William L. Redmond, PhD Earle A. Chiles Research Institute, United States ORCID logo orcid.org/0000-0002-2572-1731 Geoffrey R. Weiss, MD University of Virginia, United States ORCID logo orcid.org/0000-0001-8226-5552

Guidelines and Consensus Statements

Section Editor
Robert L. Ferris, MD, PhD University of Pittsburgh Cancer Institute, United States ORCID logo orcid.org/0000-0001-6605-2071
Associate Editors
Michael B. Atkins, MD Georgetown-Lombardi Comprehensive Cancer Center, United States ORCID logo orcid.org/0000-0003-3901-9924
Michael Platten, MD Ruprecht-Karls University Heidelberg, Germany ORCID logo orcid.org/0000-0002-4746-887X

Immune Cell Therapies and Immune Cell Engineering

Section Editor
Marcela V. Maus, MD, PhD Massachusetts General Hospital, United States
Associate Editors
Aude Chapuis, MD Fred Hutchinson Cancer Research Center, United States Yvonne Y. Chen, PhD University of California, Los Angeles, United States ORCID logo orcid.org/0000-0002-5583-119X Marco L. Davila, MD, PhD H. Lee Moffitt Cancer Center, United States ORCID logo orcid.org/0000-0002-6270-3065 Jennifer L. Guerriero, PhD Brigham and Women’s Hospital, United States ORCID logo orcid.org/0000-0002-2104-5457 Gerald Linette, MD, PhD University of Pennsylvania, United States ORCID logo orcid.org/0000-0001-6147-6115
Daniel J. Powell, Jr., PhD University of Pennsylvania, United States ORCID logo orcid.org/0000-0002-5966-8908 Marco Ruella, MD University of Pennsylvania, United States ORCID logo orcid.org/0000-0003-4301-5811 Lillian Seu, PhD Vir Biotechnology, United States ORCID logo orcid.org/0000-0002-8456-019X Nirali N. Shah, MD, MHSc National Cancer Institute, National Institutes of Health, United States ORCID logo orcid.org/0000-0002-8474-9080 Eric L. Smith, MD, PhD Memorial Sloan Kettering Cancer Center, Dana-Farber Cancer Institute, United States ORCID logo orcid.org/0000-0002-0296-7587

Immunotherapy Biomarkers

Section Editor
Ignacio Melero, MD, PhD University of Navarra, Spain ORCID logo orcid.org/0000-0002-1360-348X
Alexandra Snyder Charen, MD Generate Biomedicines, United States ORCID logo orcid.org/0000-0002-2606-3523
Deputy Editor
Kurt Schalper, MD, PhD Yale School of Medicine, United States
Associate Editors
Maria Ascierto, PhD AstraZeneca, United States John C. Castle, PhD Agenus, Germany ORCID logo orcid.org/0000-0001-8697-8955 Alessandra Cesano, MD, PhD ESSA Pharma Inc., United States Eric Deutsch, MD, PhD Gustave Roussy Cancer Campus, France Michael D. Kalos, PhD Arsenal Biosciences, United States Rejean Lapointe, PhD Universite De Montreal, University Hospital (CRCHUM), Canada Sanjeev Mariathasan, PhD Genentech, United States
Christian H. Ottensmeier, MD, PhD, FRCP University of Liverpool, United Kingdom Graham P. Pawelec, PhD University of Tuebingen, Germany ORCID logo orcid.org/0000-0002-3600-0163 Mohini Rajasagi, PhD Merck & Co., United States Licia Rivoltini, MD Fondazione IRCCS Istituto Nazionale Tumori, Italy Barbara Seliger, MD, PhD Martin Luther University Halle-Wittenberg, Germany ORCID logo orcid.org/0000-0002-5544-4958 Craig L. Slingluff Jr., MD University of Virginia, United States ORCID logo orcid.org/0000-0002-6664-4373 Jianda Yuan, MD, PhD Merck & Co., United States ORCID logo orcid.org/0000-0003-3551-4434

Oncolytic and Local Immunotherapy

Section Editor
Howard L. Kaufman, MD, FACS Massachusetts General Hospital, United States ORCID logo orcid.org/0000-0003-1131-004X
Associate Editors
John C. Bell, PhD Ottawa Hospital Research Institute, Canada ORCID logo orcid.org/0000-0002-9083-357X Kevin Harrington, PhD, FRCP, FRCR The Institute of Cancer Research, United Kingdom ORCID logo orcid.org/0000-0002-6014-348X Samuel Rabkin, PhD Massachusetts General Hospital, United States ORCID logo orcid.org/0000-0003-2344-2795
Stephen J. Russell, MD, PhD Mayo Clinic College of Medicine, United States Ann W. Silk, MD, MS Dana-Farber Cancer Institute, United States ORCID logo orcid.org/0000-0003-3877-3984 Dmitriy Zamarin, MD, PhD Memorial Sloan Kettering Cancer Center, United States ORCID logo orcid.org/0000-0002-0094-0161

Reviews

Section Editors
Sandra Demaria, MD Weill Cornell Medical College, United States ORCID logo orcid.org/0000-0003-4426-0499
Lawrence Fong, MD University of California, San Francisco, United States
Associate Editors
Michael B. Atkins, MD Georgetown-Lombardi Comprehensive Cancer Center, United States ORCID logo orcid.org/0000-0003-3901-9924 Ira Mellman, PhD Genentech, United States ORCID logo orcid.org/0000-0002-6132-7299
James J. Mule, PhD H. Lee Moffitt Cancer Center & Research Institute, United States ORCID logo orcid.org/0000-0001-7354-0516

Social Media and Consulting Editors

Social Media Associate Editor
Cheng Sun, MD, PhD University of Science and Technology of China, China
Consulting Editor
Thomas F. Gajewski, MD, PhD University of Chicago, United States

Publishing Team

Publisher: Kathleen Lyons